Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
J. pediatr. (Rio J.) ; 96(3): 318-326, May-June 2020. tab
Article in English | LILACS, ColecionaSUS, SES-SP | ID: biblio-1135033

ABSTRACT

Abstract Objective: Enuresis may have a negative impact on the self-image in childhood and adolescence. The objective of this study was to evaluate the association between enuresis and psychiatric disorders at 6 and 11 years of age. Method: 3,356 children of a birth cohort were evaluated. A standard questionnaire on urinary habits and mental health (Development and Well-Being Assessment [DAWBA]), was used. The prevalence of psychiatric disorders pursuant to the existence of enuresis and its subtypes (monosymptomatic and non-monosymptomatic), stratified by sex, was described. A logistic regression was used for adjusted analysis. Results: The prevalence of enuresis at age 6 years was of 10.2% (9% non-monosymptomatic) and, at 11 years old, of 5.4% (4.5% non-monosymptomatic). At age 6 years, boys with non-monosymptomatic enuresis showed more hyperactivity disorders than those without enuresis (6.2% vs. 2.7%, p = 0.017). At 11 years old, after adjustment, among the boys with non-monosymptomatic enuresis, the prevalence of any psychiatric disorder, hyperactivity disorders, and oppositional disorders was, respectively, 3.2, 3.4, and 2.6 times higher than in boys without enuresis; and, among the girls with non-monosymptomatic enuresis, the prevalence of any psychiatric disorder and oppositional disorders was, respectively, 4 and 5.5 times higher than among girls without enuresis. Conclusion: There is a strong association between non-monosymptomatic enuresis and psychiatric disorders at 6 and 11 years old.


Resumo Objetivo: A enurese pode ter grande impacto negativo na autoimagem na infância e adolescência. O objetivo deste estudo foi avaliar a associação entre enurese e transtornos psiquiátricos aos 6 e 11 anos de idade. Métodos: Foram avaliadas 3.356 crianças de uma coorte de nascimentos. Foi usado questionário padronizado sobre hábitos urinários e saúde mental (Development and Well-Being Assesment - DAWBA). Foi descrita a prevalência de transtornos psiquiátricos conforme a presença de enurese e seus subtipos (monossintomática e não monossintomática), estratificados por sexo. Para análise ajustada usou-se regressão logística. Resultados: A prevalência de enurese aos 6 anos foi 10,2% (9% não monossintomática) e aos 11 anos, 5,4% (4,5% não monossintomática). Aos 6 anos, meninos com enurese não monossintomática apresentaram mais transtornos de hiperatividade, em comparação com os não enuréticos (6,2% x 2,7%, p = 0,017). Aos 11 anos, após ajuste, entre os meninos com enurese não monossintomática, a prevalência de transtornos psiquiátricos, de hiperatividade e de oposição foi, respectivamente, 3,2, 3,4 e 2,6 vezes maior do que nos meninos não enuréticos; e entre as meninas com enurese não monossintomática, a prevalência de transtornos psiquiátricos e de oposição foi, respectivamente, 4 e 5,5 vezes maior do que entre meninas não enuréticas. Conclusões: Há uma forte associação entre enurese não-monossintomática e transtornos psiquiátricos aos 6 e 11 anos de idade.


Subject(s)
Humans , Male , Female , Child , Child Behavior Disorders , Self Concept , Prevalence , Surveys and Questionnaires , Cohort Studies , Nocturnal Enuresis , Mental Disorders
2.
An. bras. dermatol ; 90(1): 117-119, Jan-Feb/2015. graf
Article in English | LILACS | ID: lil-735728

ABSTRACT

Skin infections by Mycobacterium marinum are quite rare in our environment and, therefore, little studied. The majority of the lesions appear three weeks after traumas in aquariums, beaches and fish tanks. Lymph node drainage and systematization of the disease are rare and most lesions disappear in about three years. This case aims to show the effectiveness of the treatment used (lymecycline 150 mg/orally/day). This medication may be a new therapeutic option for the treatment of Mycobacterium marinum.


Subject(s)
Adolescent , Female , Humans , Anti-Bacterial Agents/therapeutic use , Lymecycline/therapeutic use , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium marinum/drug effects , Skin Diseases, Bacterial/drug therapy , Biopsy , Mycobacterium Infections, Nontuberculous/pathology , Skin Diseases, Bacterial/pathology , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL